Cargando…
ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is one of the most common malignancies and lacks reliable biomarkers for diagnosis and prognosis, which results in high incidence and mortality rates of ccRCC. In this study, ISG20, HJURP, and FOXM1 were identified as hub genes via weighted gene co-expression...
Autores principales: | Xu, Tianbo, Ruan, Hailong, Gao, Su, Liu, Jingchong, Liu, Yuenan, Song, Zhengshuai, Cao, Qi, Wang, Keshan, Bao, Lin, Liu, Di, Tong, Junwei, Shi, Jian, Liang, Huageng, Yang, Hongmei, Chen, Ke, Zhang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053611/ https://www.ncbi.nlm.nih.gov/pubmed/32003757 http://dx.doi.org/10.18632/aging.102714 |
Ejemplares similares
-
RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019) -
A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021) -
METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021) -
LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation
por: Cheng, Gong, et al.
Publicado: (2020) -
Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma
por: Xu, Jiaju, et al.
Publicado: (2021)